Argent BioPharma Limited Stock: price and insider trades · Australia
Argent BioPharma Limited: what insiders have been doing
Argent BioPharma Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 26 October 2026, 2 filings were filed, from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (1,596 companies, median 4 filings), a count of 2 filings is below the norm.
Insider buying of Argent BioPharma Limited has been absent for the past year.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.
Financial data
as of FY 2025FY ended June 2025 · cache
- ShareASXASX:2924-03087063-6A1324276
- ShareASXASX:2924-03087062-6A1324274
2 of 2 declarations
About Argent BioPharma Limited
RGT is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
